News | Radiation Dose Management | February 04, 2016

Radiation fears based on unproven theoretical model, study finds

medical imaging, low-dose radiation, cancer, LNT model study

February 4, 2016 — The widespread belief that radiation from X rays, CT scans and other medical imaging can cause cancer is based on an unproven, decades-old theoretical model, according to a study published in the American Journal of Clinical Oncology.

The model, known as linear no-threshold (LNT), is used to estimate cancer risks from low-dose radiation such as medical imaging. But risk estimates based on this model “are only theoretical and, as yet, have never been conclusively demonstrated by empirical evidence,” corresponding author James Welsh, M.D., and colleagues write. Use of the LNT model drives unfounded fears and “excessive expenditures on putative but unneeded and wasteful safety measures.”

Welsh is a Loyola University Medical Center radiation oncologist and a professor in the Department of Radiation Oncology of Loyola University Chicago Stritch School of Medicine.

The LNT model dissuades many physicians from using appropriate imaging techniques and “discourages many in the public from getting proper and needed imaging, all in the name of avoiding any radiation exposure,” Welsh and colleagues write.

The authors reexamined the original studies, dating back more than 70 years, which led to adoption of the LNT model. This reappraisal found that the data reported in those studies do not actually support the LNT model.

In the LNT model, the well-established cancer-causing effects of high doses of radiation are extended downward in a straight line to very low doses. The LNT model assumes there is no safe dose of radiation, no matter how small. However, the human body has evolved the ability to repair damage from low-dose radiation that naturally occurs in the environment.

The LNT model dates to studies, conducted in the 1940s, of fruit flies exposed to various doses of radiation. The scientists who conducted those studies concluded there is no safe level of radiation, thus giving rise to the LNT model that is used to this day. But their conclusion was unwarranted because their experiments had not been done at truly low doses. A study exposing fruit flies to low-dose radiation wasn’t conducted until 2009, and this study did not support the LNT model.

Studies of atomic bomb survivors and other epidemiological studies of human populations have never conclusively demonstrated that low-dose radiation exposure can cause cancer.

Any claim that low-dose radiation from medical imaging procedures is known to cause cancer “should be vigorously challenged, because it serves to alarm and perhaps harm, rather than educate,” Welsh and colleagues write.

The authors conclude the LNT model “should finally and decisively be abandoned.”

The study is titled “The birth of the illegitimate linear no-threshold model – an invalid paradigm for estimating risk following low-dose radiation exposure.”

In addition to Welsh, co-authors are: Jeffry Siegel, Ph.D., president and CEO of Nuclear Physics Enterprises (first author); Charles Pennington of NAC International and Bill Sacks, M.D., Ph.D., emeritus medical officer in the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health.

 

Read the article, “Public Perception of Long-term Health Effects of Atomic Bomb Radiation Worse than Reality.”

 

Read the article “CT Cancer Risk Poorly Understood by Many Healthcare Providers.”

 

For more information: www.journals.lww.com/amjclinicaloncology


Related Content

News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Lung Imaging

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 21, 2024 — According to a newly-published study of nearly 5,000 screening mammograms interpreted by an FDA-approved ...

Time May 21, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo ...

Time May 20, 2024
arrow
News | Cardiac Imaging

May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the ...

Time May 17, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | RSNA

May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of ...

Time May 07, 2024
arrow
Subscribe Now